Reid Laurence Insider Trades

Insider Trading History

Track insider trading activity for Reid Laurence. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $0 0 shares
Last Trade
Jun 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$459k 17,000 shares
$27.00
$27.00
Metagenomi
Metagenomi MGX
Director
Holding Value $23k 17,400 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.4k 17,400 shares
$1.23
$1.32
Metagenomi
Metagenomi MGX
Director
Holding Value $55.4k 42,000 shares
Last Trade
Sep 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.4k 42,000 shares
$1.82
$1.32
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $459k 17,000 shares
Last Trade
Nov 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$171k 17,000 shares
$10.07
$27.00
Decibel Therapeutics
Decibel Therapeutics DBTX
See Remarks
Holding Value $0 0 shares
Last Trade
Sep 25, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.62M 1,552,888 shares
$4.91
$4.91
Decibel Therapeutics
Decibel Therapeutics DBTX
See Remarks
Holding Value $1.08M 220,849 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$996k 267,000 shares
$3.73
$4.91
Decibel Therapeutics
Decibel Therapeutics DBTX
See Remarks
Holding Value $921k 187,500 shares
Last Trade
Feb 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 187,500 shares
$3.50
$4.91
Decibel Therapeutics
Decibel Therapeutics DBTX
President And Chief Executive
Holding Value $127k 25,849 shares
Last Trade
Sep 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$76.4k 10,000 shares
$7.64
$4.91
Decibel Therapeutics
Decibel Therapeutics DBTX
See Remarks
Holding Value $77.8k 15,849 shares
Last Trade
Feb 11, 2021 Sale
No data
No data
$4.91
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $5.84M 20,905 shares
Last Trade
Dec 31, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 17,000 shares
$97.00
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $5.05M 18,103 shares
Last Trade
Dec 31, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$272k 2,802 shares
$97.00
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $37.3M 133,609 shares
Last Trade
Dec 31, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 17,000 shares
$97.00
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $1.86M 6,667 shares
Last Trade
Dec 12, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$670k 6,667 shares
$100.45
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $42M 150,609 shares
Last Trade
Nov 18, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$900k 10,000 shares
$89.95
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $2.37M 8,492 shares
Last Trade
Nov 18, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$907k 10,000 shares
$90.66
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $3.88M 13,905 shares
Last Trade
Nov 18, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$900k 10,000 shares
$89.95
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $3.04M 10,905 shares
Last Trade
Aug 18, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$909k 13,500 shares
$67.33
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $4.19M 15,000 shares
Last Trade
Aug 18, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$919k 13,500 shares
$68.05
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $4.86M 17,405 shares
Last Trade
Aug 18, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$919k 13,500 shares
$68.05
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $4.88M 17,500 shares
Last Trade
May 19, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$787k 13,500 shares
$58.26
$279.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up